
Sign up to save your podcasts
Or


This episode goes into the details of post-menopausal osteoporosis and how estrogen deficiency leads to reduced bone strength.
This episode takes a deep dive into glucocorticoid-induced osteoporosis and how steroids can drastically reduce bone strength, even for a short duration of therapy.
This episode describes the procedure and pitfalls of AVS (everyone’s favorite test)
Core AVS Indices and Interpretation
Adrenal venous sampling relies on three sequential biochemical indices to determine whether primary aldosteronism is unilateral or bilateral.
The first step calculates the Selectivity Index to confirm that the catheter tip was positioned correctly inside the adrenal lumen rather than a surrounding vessel. The index is determined by dividing the adrenal vein cortisol concentration by the peripheral vein cortisol concentration. Under unstimulated baseline conditions, a ratio greater than 2.0 verifies successful cannulation, whereas an ACTH-stimulated protocol requires a ratio greater than 5.0 due to increased cortical hormone output. If a sample fails to meet these specific thresholds, the blood is considered contaminated with peripheral circulation, rendering all subsequent calculations invalid and uninterpretable.
Once bilateral selectivity is confirmed, the Lateralization Index determines the source of aldosterone overproduction. The raw aldosterone concentration from each side is divided by its matching cortisol concentration to correct for asymmetrical blood flow and dilutional differences between the left and right adrenal veins. The final index is calculated by dividing the corrected ratio of the dominant high-secreting side by the corrected ratio of the non-dominant low-secreting side. An unstimulated ratio greater than 2.0 to 3.0 or an ACTH-stimulated ratio greater than 4.0 confirms unilateral disease, identifying the patient as a candidate for surgical adrenalectomy.
The Contralateral Suppression Index evaluates whether the unaffected, non-dominant gland is appropriately down-regulated by systemic feedback loops. It is calculated by dividing the corrected aldosterone-to-cortisol ratio of the non-dominant adrenal vein by the aldosterone-to-cortisol ratio of a peripheral vein. A ratio less than 1.0 confirms true physiological suppression, showing that the normal gland has gone dormant in response to the low-renin state caused by the contralateral tumor. If the index is 1.0 or greater, the non-dominant gland is actively manufacturing aldosterone independently, which strongly signals underlying bilateral hyperplasia despite a borderline lateralization index.
Autonomous cortisol secretion from an adrenal mass creates severe diagnostic pitfalls when evaluating primary aldosteronism via adrenal venous sampling. The excess cortisol triggers negative feedback on the hypothalamus and pituitary gland, downregulating adrenocorticotropic hormone (ACTH) secretion. Deprived of ACTH, the normal contralateral adrenal gland suppresses its own cortisol output. During an unstimulated procedure, this drop in cortisol falsely deflates the normal side's Selectivity Index, erroneously suggesting a catheter placement failure. Furthermore, using this artificially low cortisol level as a denominator falsely inflates the non-dominant side's corrected aldosterone ratio. This mathematical artifact can completely mask a true unilateral tumor or turn a bilateral hyperplasia case into a false unilateral diagnosis, risking an inappropriate or failed surgery.
Exogenous ACTH stimulation overcomes these pitfalls by directly binding to melanocortin 2 receptors on both glands. This pharmacological intervention overrides central pituitary suppression and forces the dormant, healthy gland to resume high-volume cortisol output, restoring a symmetrical biochemical baseline. However, ACTH can hyper-stimulate aldosterone secretion in adenomas that overexpress ACTH receptors, which alters standard lateralization index cutoffs. Measuring plasma free metanephrines provides an even better alternative for verifying selectivity because these medullary markers bypass the cortical steroid pathways entirely, remaining completely unaffected by cortisol autonomy or central pituitary feedback loops.
This episode compares the effectiveness of levothyroxine (LT4), combination therapy (LT4+LT3), and desiccated thyroid extract (DTE) in treating adults with primary hypothyroidism.
The 2021 crossover trial by Shakir & Hoang et al. evaluated 75 hypothyroid patients across three 22-week treatment arms: Levothyroxine (LT4) monotherapy, LT4 + Liothyronine (LT3), and Desiccated Thyroid Extract (DTE). Doses maintained a euthyroid TSH range.
Primary Findings
As a whole group, data revealed no significant differences in symptoms, quality of life, or cognitive function between therapies:
- Thyroid Symptom Questionnaire (TSQ-36): No distinct variance (P = 0.357).
- General Health Questionnaire (GHQ-12): Equivalent well-being (P = 0.891).
- Wechsler Memory Scale (WMS-IV): No objective memory divergence.
Subgroup Outcomes
Biochemical profiles showed higher T3 and lower T4 in combination and DTE phases, but overall clinical outcomes matched. However, a subgroup of the most symptomatic patients at baseline reported a strong preference and significant symptom reduction on T3-containing regimens.
Conclusion
For the aggregate population, DTE and combination therapies offer no clinical advantage over standard LT4 monotherapy. T3 options remain a targeted alternative for individuals with persistent residual symptoms.
This podcast episode explores the complex differential diagnosis of inappropriate thyroid-stimulating hormone secretion, a clinical paradox characterized by elevated free thyroxine alongside unsuppressed thyroid-stimulating hormone. Listeners will gain clear insights into distinguishing true central pathologies, such as thyrotropin-secreting pituitary adenomas and resistance to thyroid hormone beta, from common analytical artifacts including familial dysalbuminemic hyperthyroxinemia, heterophile antibodies, anti-thyroid hormone autoantibodies, and high-dose biotin interference. The discussion outlines precise diagnostic strategies, emphasizing tissue biomarkers like sex hormone-binding globulin, alpha-subunit to thyroid-stimulating hormone molar ratios, dynamic thyrotropin-releasing hormone stimulation testing, and gold-standard equilibrium dialysis to prevent inappropriate surgical or ablative interventions.
This episode reviews functional hypogonadism in obese males tailored for practicing endocrinologists. The discussion explores adipokine-mediated hypothalamic-pituitary-gonadal axis suppression, aromatase hyperactivity converting testosterone to estradiol, central leptin resistance, and sleep apnea induced hypoxia. Listeners will review diagnostic criteria using liquid chromatography-tandem mass spectrometry and equilibrium dialysis alongside strategies to exclude structural lesions. Finally, the episode highlights weight reduction and bariatric surgery as primary reversible therapies, compares the off-label utility of selective estrogen receptor modulators and aromatase inhibitors for fertility preservation, and outlines safety monitoring protocols for testosterone replacement therapy.
This episode provides a high level review of medication related osteonecrosis of the jaw tailored for practicing endocrinologists. The discussion anchors on current diagnostic criteria in patients utilizing antiresorptive or antiangiogenic therapies. Listeners will review the anatomical vulnerabilities of the mandible, multi factorial pathophysiology including osteoclast suppression and angiogenesis inhibition, and risk stratification across osteoporosis and oncology dosing regimens. Finally, the episode outlines preventative pre treatment protocols, the drug holiday debate, and conservative versus surgical management strategies.
This podcast episode provides a concise high-level review of hungry bone syndrome, focusing on the rapid post-surgical drop in parathyroid hormone that triggers profound hypocalcemia, hypophosphatemia, and hypomagnesemia. Designed for practicing endocrinologists, the discussion covers preoperative risk stratification, including advanced age, elevated alkaline phosphatase, and severe vitamin D deficiency. Listeners will review the critical laboratory trends that differentiate this condition from transient hypoparathyroidism, specifically noting the diagnostic value of low serum phosphate. Finally, the episode outlines immediate postoperative surveillance protocols alongside aggressive multi-phased management strategies utilizing intravenous calcium gluconate, high-dose oral elemental calcium, active calcitriol, and concurrent magnesium repletion.
This podcast episode delivers a high-yield clinical review of 24-hour urine calcium interpretation for practicing endocrinologists managing complex calcium homeostasis disorders. The discussion details the physiology of renal calcium handling and establishes strict reference parameters to accurately identify hypercalciuria and hypocalciuria. Listeners will explore the contrasting urinary profiles of primary hyperparathyroidism and familial hypocalciuric hypercalcemia, emphasizing the diagnostic value and limitations of the calcium-creatinine clearance ratio. Finally, the episode addresses critical clinical confounders, including the cellular mechanisms of thiazide diuretics, the mathematical distortion of clearance ratios in chronic kidney disease, and the metabolic impact of idiopathic hypercalciuria and intestinal malabsorption.
This episode explores the physiological mechanisms governing dual energy x ray absorptiometry site selection, emphasizing why the lumbar spine, proximal femur, and one third radius must be evaluated to capture skeletal heterogeneity. Listeners will review how trabecular bone, comprising most of the lumbar spine, drives rapid metabolic turnover and serves as an early indicator of estrogen deficiency or anabolic response. Conversely, dense cortical sites like the one third radius reveal distinct pathology, such as parathyroid hormone induced intracortical porosity in primary hyperparathyroidism. The discussion provides a big picture view of managing t score discordance and mitigating degenerative artifacts in aging populations.
From the publisher's feed